Sunday, July 22, 2018
Company News: Page (1) of 1 - 06/11/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Project HOPE Responds to Urgent Health Needs from Guatemala’s Fuego Volcano

(June 11, 2018)

Millwood, VA, June 11, 2018 (GLOBE NEWSWIRE) -- Project HOPE announced the deployment of an emergency medical response team to Guatemala as fresh lava flows from the Fuego volcano, prolonging a disaster that has displaced thousands of people.

Fuego’s catastrophic eruption started on June 3rd, spreading lava and hot clouds of volcanic ash and toxic gases, killing 110 people and leaving 200 missing. It’s estimated that 1.7 million people have been affected by Fuego and thousands have crammed into shelters.

“We anticipate that health needs will rise quickly in Guatemala. Communities situated near the volcano are especially at risk and local health workers are under enormous strain to address the challenges caused by this disaster,” said Chris Skopec, Project HOPE Executive Vice President, responsible for Global Health and Disaster Response Programs.

Project HOPE’s team, including physicians, nurse practitioners, and logistics experts will assess critical health needs and provide care to people affected by the disaster. The first deployment will arrive on Tuesday, June 12th, and additional rotations of medical volunteers are expected to deploy in the weeks ahead.

Authorities in Guatemala have warned that Fuego, the most violent eruption in four decades, is still active and poses substantial health risks. Project HOPE will provide medicines and supplies to Guatemala based on the needs outlined by the government.

“Our team will collaborate with the Guatemalan government and local partners to ensure we deliver assistance where it is needed most.  The Guatemalan government has requested international assistance including water filters, medicines, medical supplies, mobile hospitals, and medical support,” said Skopec.

Project HOPE has responded to every major disaster since the 2004 Indonesian tsunami with medical volunteer support, donations of medicines and supplies, and long-term efforts to rebuild damaged health systems.  Most recently, HOPE provided care for people impacted by Hurricanes Harvey, Irma, and Maria in 2017 and HOPE is still in Puerto Rico supporting health needs. In Guatemala, HOPE provided humanitarian aid following Hurricane Stan in 2005 and has implemented maternal and child health programs in the country since then.

About Project HOPE

Founded in 1958, Project HOPE is a leader in global health development and emergency relief programs. An international nonprofit organization, we save lives and improve health, especially among women and children. We accomplish our mission by improving the knowledge, abilities and tools of the health workforce to deliver high quality health services to communities in need. With programs in more than 25 countries, we work at the epicenter of today’s greatest health challenges including infectious and chronic diseases, disasters and health crises, maternal, neonatal and child health and the policies that impact how health care is delivered. Learn more at and follow us on Twitter @projecthopeorg.


CONTACT: Geraldine CarrollProject [email protected]

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines